Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Global Tyrosine Protein Kinase JAK2 (Janus Kinase 2 or JAK2 or EC 2.7.10.2) Pipeline Review 2016 - Research and Markets

Research and Markets
Posted on: 25 Aug 16

Research and Markets has announced the addition of the "Tyrosine Protein Kinase JAK2 (Janus Kinase 2 or JAK2 or EC 2.7.10.2) - Pipeline Review, H2 2016" drug pipelines to their offering.

This report provides comprehensive information on the therapeutic development for Tyrosine Protein Kinase JAK2, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Tyrosine Protein Kinase JAK2 and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

  1. Introduction
  2. Tyrosine Protein Kinase JAK2 Overview
  3. Therapeutics Development
  4. Pipeline Products for Tyrosine Protein Kinase JAK2 - Overview
  5. Pipeline Products for Tyrosine Protein Kinase JAK2 - Comparative Analysis
  6. Tyrosine Protein Kinase JAK2 - Therapeutics under Development by Companies
  7. Tyrosine Protein Kinase JAK2 - Therapeutics under Investigation by Universities/Institutes
  8. Tyrosine Protein Kinase JAK2 Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Tyrosine Protein Kinase JAK2 - Products under Development by Companies
  13. Tyrosine Protein Kinase JAK2 - Products under Investigation by Universities/Institutes
  14. Tyrosine Protein Kinase JAK2 - Companies Involved in Therapeutics Development
  • Aerie Pharmaceuticals, Inc.
  • Aptose Biosciences Inc.
  • Astex Pharmaceuticals, Inc.
  • AstraZeneca Plc
  • Bristol-Myers Squibb Company
  • Celon Pharma Sp. z o.o.
  • Concert Pharmaceuticals, Inc.
  • CTI BioPharma Corp.
  • Daiichi Sankyo Company, Limited
  • Eli Lilly and Company

For more information about this drug pipelines visit http://www.researchandmarkets.com/research/b6hbc7/tyrosine_protein

Related Topics: Enzymes

View source version on businesswire.com: http://www.businesswire.com/news/home/20160825005857/en/

Business Wire
www.businesswire.com

Last updated on: 25/08/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.